Diaceutics PLC announced revenue results for the six months ended 30 June 2023. For the period, the company reported revenue grew 32% to £9.9 million in against £7.5 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
103 GBX | 0.00% | -0.48% | +18.39% |
Apr. 02 | Roadside shares suspended; Adnams looks for funds | AN |
Mar. 21 | Diaceutics upgrades diagnositc commercialisation platform, DXRX | AN |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.39% | 108M | |
+5.73% | 4.03B | |
+24.05% | 1.89B | |
-36.44% | 1.84B | |
-1.59% | 1.71B | |
-15.36% | 1.58B | |
-23.48% | 1.36B | |
-5.20% | 1.16B | |
-6.85% | 1.05B | |
+119.33% | 694M |
- Stock Market
- Equities
- DXRX Stock
- News Diaceutics PLC
- Diaceutics PLC Announces Revenue Results for the Six Months Ended 30 June 2023